Commission launches consultation on responsible nano research

The European Commission has launched a consultation on responsible research in nanosciences and nanotechnologies.

The consultation is part of the Commission's plan to suggest that the EU Member States sign up to a Code of Conduct for this emerging area of science. A broad spectrum of society is addressed by the consultation, from the scientific community and industry to civil society, policy-makers, media and the general public.

"Nanosciences and nanotechnologies have the potential to drive growth and jobs in Europe, and their development and use should not be delayed, unbalanced or left to chance," said EU Science and Research Commissioner Janez Potocnik. "It is important that we pursue this knowledge with full understanding of the possible implications of these new areas of science, and that we do so openly and involving all concerned."

The Commissioner also stressed that the consultation demonstrates the Commission's commitment to 'developing the potential of nanosciences with appropriate safeguards'.

Estimates as to the market potential of nanotechnology products vary, but are all very positive. The Mitsubishi Institute estimated in 2002 that the market would be worth USD 150 billion (around €110 billion) by 2010, while in 2004 the Lux Research group predicted that the market would be worth USD 2.6 trillion (around €1.9 trillion) by 2014.

If this latter estimate is proved to be accurate, it will mean the nanoscience and nanotechnology market overtaking the information and communication technologies (ICT) market, and growing to 10 times the size of the biotechnology market.

However, concerns over safety have put the brakes on some research into the nanosciences and nanotechnologies. The principal concerns cover the ability of nanoparticles to cross natural bio-boundaries, and the prospect of connecting living creatures and human-made materials and systems.

These concerns have led to the development of a new area of research: the responsible management and control of nanosciences. This involves ethics, safety, the environment, individual rights, and the protection of personal data.

The Code of Conduct would encompass basic principles on which to base future developments in nano research, and would invite signatories to take concrete action to ensure that nanotechnologies are developed in a safe manner.

The consultation will close on 21 September.

For further information, please visit:
http://europa.eu/sinapse/directaccess/
science-and-society/public-debates/nano-recommendation/

Copyright ©European Communities, 2007
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...